4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-003914
Director sold 6,000 shares at an average $65.88 ($395,253)
- Director acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
GRIFFIN MICHELLE RENEE · Director
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-14 | Exercise or conversion : show line 1 in the form | +6,000 | $7.80 | $46,800 | 6,000 | D |
| 2021-01-14 | Sale : show line 2 in the form | −5,041 | $65.77 | $331,547 | 959 | D |
| 2021-01-14 | Sale : show line 3 in the form | −959 | $66.43 | $63,706 | 0 | D |
| Open-market sales · 6,000 sh · avg $65.88 · $395,253 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-14 | Exercise or conversion : show line 4 in the form Stock Option (Right to Buy) | −6,000 | 95,000 | D |
Loading xslF345X03/doc4.xml…